Nigel J. Parr
Wirral University Teaching Hospital NHS Foundation Trust(GB)
Publications by Year
Research Areas
Protein Degradation and Inhibitors, Prostate Cancer Treatment and Research, Multiple Myeloma Research and Treatments, Prostate Cancer Diagnosis and Treatment, Bone health and treatments
Most-Cited Works
- → Discovery of Epigenetic Regulator I-BET762: Lead Optimization to Afford a Clinical Candidate Inhibitor of the BET Bromodomains(2013)302 cited
- → Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia Therapy(2015)225 cited
- → BET Inhibition Silences Expression of MYCN and BCL2 and Induces Cytotoxicity in Neuroblastoma Tumor Models(2013)203 cited
- → Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762(2013)202 cited
- → Phase 1 Study of Molibresib (GSK525762), a Bromodomain and Extra-Terminal Domain Protein Inhibitor, in NUT Carcinoma and Other Solid Tumors(2019)199 cited
- → Selective inhibition of CD4 + T-cell cytokine production and autoimmunity by BET protein and c-Myc inhibitors(2012)184 cited